Cargando…
Low-dose aspirin for primary and secondary prevention of cardiovascular events in Denmark 1998–2018
Randomised controlled trials have shown a neutral or even unfavourable risk–benefit balance of aspirin for primary prevention of cardiovascular events. Using Danish nationwide registries, we investigated aspirin use and associated risks during the past two decades (1998–2018). We linked individual p...
Autores principales: | Christensen, Mikkel B., Jimenez-Solem, Espen, Ernst, Martin. T., Schmidt, Morten, Pottegård, Anton, Grove, Erik L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245534/ https://www.ncbi.nlm.nih.gov/pubmed/34193948 http://dx.doi.org/10.1038/s41598-021-93179-8 |
Ejemplares similares
-
Statin Discontinuation and Cardiovascular Events Among Older People in Denmark
por: Thompson, Wade, et al.
Publicado: (2021) -
Who prescribes quetiapine in Denmark?
por: Højlund, Mikkel, et al.
Publicado: (2022) -
Short‐term mortality following tramadol poisonings in Denmark
por: Sørensen, Anne Mette Skov, et al.
Publicado: (2022) -
Prophylactic anticoagulation with low molecular weight heparin in COVID-19: cohort studies in Denmark and Sweden
por: Lund, Lars Christian, et al.
Publicado: (2022) -
Trends in Incidence of Intracerebral Hemorrhage and Association With Antithrombotic Drug Use in Denmark, 2005-2018
por: Hald, Stine Munk, et al.
Publicado: (2021)